Sputum smear microscopy result: a predictor for drug-resistant tuberculosis?

Area of Science:

• Public Health
• Infectious Diseases
• Microbiology

Background:

• Continuous surveillance systems for tuberculosis (TB) are not yet established globally.
• Representative surveys of TB patients are vital for assessing drug-resistant TB.
• Current resource allocation relies on available TB patient data.

Purpose of the Study:

• To evaluate the justification for restricting TB patient surveys to sputum smear-positive individuals.
• To explore the relationship between drug resistance and sputum smear status in TB patients.
• To anticipate future data availability for drug resistance in the broader TB patient population.

Main Methods:

• Analysis of existing data on drug-resistant TB prevalence.
• Review of recommendations for TB patient surveys.
• Consideration of logistical factors in survey design.
• Assessment of the association between drug resistance and sputum smear microscopy.

Main Results:

• Limited data suggest restricting surveys to sputum smear-positive patients is currently justified.
• Logistical simplification is a key factor supporting this recommendation.
• Evidence linking drug resistance and sputum smear status is limited and setting-dependent.

Conclusions:

• Representative surveys remain essential for understanding drug-resistant TB burden and resource allocation.
• The relationship between drug resistance and smear status requires further investigation across diverse settings.
• Advancements in molecular diagnostics will increase data on drug resistance in all TB patients, supporting the End TB Strategy.